Bile duct stents: Is there an increased rate of complications in patients receiving chemotherapy?

European Journal of Cancer Part A

Volumn 33, Issue 2, 1997, Pages 209-213

  Lofts, F J ^a   Evans, T R J ^a   Mansi, J L ^a   Glees, J P ^a   Knight, M J ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Biliary stents; Chemotherapy; Pancreatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PALLIATIVE THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; STENT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BILIARY TRACT NEOPLASMS; CHOLESTASIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES; STENTS;

EID: 0030891236     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00365-6     Document Type: Article

References (17)

1. Shepard HA, Royle G, Ross APR, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomised trial. Br J Surg 1988, 75, 1166-1168.
2. Coene PPLO, Groen AK, Cheng J, Out MMT, Tytgat GNJ, Huibregtse K. Clogging of biliary endoprosthesis: a new perspective. Gut 1990, 31, 913-917.
3. Leung JWC, Ling TKW, Kung JLS, Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointest Endosc 1988, 34, 19-22.
4. Huibregtse K, Katon RM, Coene PP, Tytgat GNJ. Endoscopic palliative treatment in pancreative cancer. Gastrointest Endosc 1986, 32, 334-338.
5. Reichen J. Pharmacologic treatment of cholestasis. Semin Liver Dis 1993, 13, 302-315.
6. Smit JM, Out MMJ, Groen AK, et al. A placebo controlled study on the efficiency of aspirin and deoxycycline in preventing clogging of biliary endoprostheses. Gastrointest Endosc 1989, 35, 485-489.
7. Barrioz T, Ingrand P, Besson L, de Ledinghen V, Silvain C, Beauchant M. Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin. Lancet 1994, 344, 581-582.
8. Evans TRJ, Lofts FJ, Mansi JL, Glees JP, Knight MJ, Dalgleish AG. A phase II study of continuous infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer 1996, 73, 1260-1264.
9. Davids PHP, Groen AK, Rauws EAJ, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992, 340, 1488-1492.
10. Wagner H, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 1993, 25, 213-218.
11. Siegel JH, Pullano W, Kodsi B, Cooperman A, Ramsey W. Optimal palliation of malignant bile duct obstruction: experience with endoscopie 12 French prostheses. Endoscopy 1988, 20, 137-141.
12. Matsuda Y, Shimakura K, Akamatsu T. Factors affecting the patency of stents in malignant biliary obstructive disease: univariate and multivariate analysis. Am J Gastroenterology 1991, 86, 843-849.
13. Frankes JT, Johanson JF, Stake JJ. Optimal timing for stent replacement in malignant biliary tract obstruction. Gastrointest Endosc 1993, 39, 164-167.
14. Knyrim K, Wagner HJ, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993, 25, 207-212.
15. O'Brien S, Hatfield ARW, Craig PI, Williams SP. A three year follow up of self expanding metal stents in the endoscopic palliation of long term survivors with malignant biliary obstruction. Gut 1995, 36, 618-621.
16. Mathieson JR, McLoughlin RF, Cooperberg PL, et al. Malignant obstruction of the common bile duct: long-term results of Gianturco-Rosch metal stents used as initial treatment. Radiology 1994, 192, 663-667.
17. Speer AG, Cotton PB, Russel RC, et al. Randomised trial of endoscopie versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987, ii, 57-62.